Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 April 2025 | Story Precious Shamase | Photo Supplied
Qwaqwa NAS Achievements
From left to right Prof Richard Ocaya is an Associate Professor in the Department of Physics, Dr Tebogo Motsei and Dr Kamohelo Tshabalala

The Faculty of Natural and Agricultural Sciences (NAS) at the University of the Free State (UFS) Qwaqwa Campus is celebrating a year of remarkable achievements, showcasing the dedication and brilliance of its students and faculty. The 2024 academic year has been marked by outstanding academic performance, prestigious awards, and groundbreaking research, solidifying the faculty's commitment to excellence.


Academic excellence shines bright

The faculty's commitment to rigorous academic standards has yielded impressive results. This year, four doctoral candidates successfully obtained their PhDs, contributing valuable research to their respective fields. Furthermore, the dedication of the honours and master’s students was evident in their exceptional performance. Out of 25 honours students, an impressive 11 achieved distinctions, demonstrating their mastery of their subjects. Similarly, 5 out of 10 master’s students passed with distinctions, a testament to their advanced research capabilities and academic prowess.


Dr Tebogo Motsei: A beacon of innovation and excellence

Among the faculty's many successes, the achievement of Dr Tebogo Motsei stands out as a testament to the calibre of talent being nurtured on the UFS Qwaqwa Campus. Dr Motsei, who recently graduated from the campus, was awarded the prestigious CV Raman Scholarship by the Government of the Republic of India – a recognition bestowed upon only the most promising postgraduate students.

This highly competitive scholarship, named after the Nobel prize-winning physicist Chandrasekhara Venkata Raman, provided recipients with a six-month research opportunity in India. Dr Motsei conducted her research at the esteemed Central Electrochemical Research Institute (CECRI), under the guidance of Prof Arul Manuel Stephan and Prof Sabu Thomas, Vice-Chancellor of the Mahatma Gandhi University. CECRI – one of the most difficult Indian institutes to get admitted into – is part of the Council for Scientific and Industrial Research (CSIR).

Dr Motsei’s research focused on sodium-ion batteries and supercapacitors with lithium-sulphur integration, resulting in significant advancements in energy storage devices. Her innovative work has the potential to revolutionise the field, contributing to more efficient and sustainable energy solutions.   

Adding to her achievements, Dr Motsei also established Lesedi Innovations Pty, a company dedicated to the manufacturing of button batteries and cells of the CR2032 and 18650 form factors. This entrepreneurial endeavour highlights her commitment to translating research into practical applications that benefit society.

For her PhD studies, she was supervised by Prof Richard Ocaya in the Department of Physics, and co-supervised by Dr Kamohelo Tshabalala, Senior Lecturer in the Department of Physics. Prof Ocaya, proud of Motsei’s achievements, believes that this fellowship not only serves as a great motivation for students – especially on the Qwaqwa Campus – but also highlights the global relevance of the UFS, particularly the Department of Physics.


A message of pride and congratulations

Prof Aliza le Roux, Assistant Dean of the Faculty of Natural and Agricultural Sciences, expressed her immense pride in the students and staff. "I would like to congratulate the NAS students and staff members on this fantastic achievement – it’s a sign of people going out of their way to do their best and make their research work despite any obstacles thrown in their way. These distinctions show that we have smart, dedicated, creative people in NAS, and I’m very proud of all of them. For students, this means great opportunities ahead, and for staff, it is a sure sign that they did something right in their mentorship and teaching. Thank you to this wonderful team," concluded Prof Le Roux.

The UFS Qwaqwa Campus congratulates all the graduates, distinguished students, and dedicated staff of the Faculty of Natural and Agricultural Sciences. Their accomplishments are a testament to the university's commitment to fostering academic excellence and innovation. The faculty continues to fly the UFS flag high, inspiring future generations of scientists and researchers.

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept